Dissenting Views
[To accompany H.R. 3284]
The Committee on Ways and Means, to whom was referred the
bill (H.R. 3284) to require the Secretary of Health and Human
Services to submit an annual report on the impact of certain
Medicare regulations on provider and payer consolidation,
having considered the same, reports favorably thereon with an
amendment and recommends that the bill as amended do pass.
CONTENTS
Page
I. SUMMARY AND BACKGROUND...........................................3
A. Purpose and Summary................................. 3
B. Background and Need for Legislation................. 3
C. Legislative History................................. 3
D. Legislative History................................. 3
II. EXPLANATION OF THE BILL..........................................4
A. Ensuring HHS Considers the Potential Impacts of
Medicare Regulations and Payments Have on
Consolidation and Competition...................... 4
III. VOTE OF THE COMMITTEE............................................4
IV. BUDGET EFFECTS OF THE BILL.......................................5
A. Committee Estimate of Budgetary Effects............. 5
B. Statement Regarding New Budget Authority and Tax
Expenditures Budget Authority...................... 5
V. OTHER MATTERS TO BE DISCUSSED UNDER THE RULES OF THE HOUSE.......5
A. Committee Oversight Findings and Recommendations.... 5
B. Statement of General Performance Goals and
Objectives......................................... 5
C. Information Relating to Unfunded Mandates........... 6
D. Congressional Earmarks, Limited Tax Benefits, and
Limited Tariff Benefits............................ 6
E. Duplication of Federal Programs..................... 6
VI. CHANGES IN EXISTING LAW MADE BY THE BILL, AS REPORTED............6
Changes in Existing Law Proposed by the Bill, as
Reported........................................... 6
VII. DISSENTING VIEWS................................................15
The amendment is as follows:
Strike all after the enacting clause and insert the
following:
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Providers and Payers COMPETE Act''.
SEC. 2. ANNUAL REPORT ON THE IMPACT OF CERTAIN MEDICARE REGULATIONS ON
PROVIDER AND PAYER CONSOLIDATION; PUBLIC COMMENT ON
PROVIDER AND PAYER CONSOLIDATION FOR CERTAIN
PROPOSED RULES.
(a) Annual Report.--Not later than December 31, 2026, and annually
thereafter, the Secretary of Health and Human Services (in this section
referred to as the ``Secretary'') shall submit to Congress a report on
the impact in the aggregate on provider and payer consolidation with
respect to regulations and rules for parts A, B, C, and D of title
XVIII of the Social Security Act (42 U.S.C. 1395c et seq.) implemented
in the calendar year immediately prior to such report. Such report
shall include regulations and rules that--
(1) implement a change to an applicable payment system, a
rate schedule, or another payment system under parts A, B, C,
or D of such title; or
(2) result in a significant rule effecting provider or payer
consolidation.
(b) Public Comment on Impact to Provider and Payer Consolidation.--
Beginning for 2025, as part of any notice and comment rulemaking
process that could result in a significant rule affecting provider or
payer consolidation with respect to a proposed rule for parts A, B, C,
and D of title XVIII of the Social Security Act (42 U.S.C. 1395c et
seq.), the Secretary shall seek public comment on the potential impact
of such proposed rule on provider and payer consolidation in the
aggregate.
(c) Definitions.--In this section:
(1) Provider and payer consolidation.--The term ``provider
and payer consolidation'' includes the vertical or horizontal
integration among providers of services (as defined in
subsection (u) of section 1861 of the Social Security Act (42
U.S.C. 1395x)), suppliers (as defined in subsection (d) of such
section), accountable care organizations under section 1899 of
the Social Security Act (42 U.S.C. 1395jjj), Medicare Advantage
organizations, PDP sponsors, pharmacy benefit managers,
pharmacies, and integrated delivery systems.
(2) Applicable payment system.--The term ``applicable payment
system'' includes--
(A) with respect to outpatient hospital services, the
prospective payment system for covered OPD services
established under section 1833(t) of such Act (42
U.S.C. 1395(l)); and
(B) with respect to physicians' services, the
physician fee schedules established under section 1848
of such Act (42 U.S.C. 1395w-4).
SEC. 3. CONSIDERATION OF EFFECTS ON PROVIDER AND PAYER CONSOLIDATION
WITH RESPECT TO CMI MODELS.
(a) In General.--Section 1115A(b)(4)(A) of the Social Security Act
(42 U.S.C. 1315a(b)(4)(A)) is amended--
(1) in clause (i), by striking at the end ``and'';
(2) in clause (ii), by striking the period at the end and
inserting ``; and''; and
(3) by adding at the end the following new clause:
``(iii) the extent to which, and how, the
model has affected and could affect provider
and payer consolidation, which includes the
vertical or horizontal integration among
providers of services (as defined in subsection
(u) of section 1861), suppliers (as defined in
subsection (d) of such section), and
accountable care organizations under section
1899, or pursuant to models under this
section.''.
(b) Effective Date.--The amendments made by subsection (a) shall
apply with respect to models tested on or after January 1, 2025.
I. SUMMARY AND BACKGROUND
A. Purpose and Summary
The bill, H.R. 3284, the ``Providers and Payers COMPETE
Act,'' as ordered reported by the Committee on Ways and Means
on July 26, 2023, to require the Secretary of Health and Human
Services to submit an annual report on the impact of certain
Medicare regulations on provider and payer consolidation.
B. Background and Need for Legislation
On May 15, 2023, Representative Burgess (R-TX),
Representative Dingell (D-MI), Representative Ferguson (R-GA),
and Representative Bilirakis (R-FL) introduced H.R. 3284,
legislation to ensure HHS is considering the impact of certain
regulations and payment models on health care consolidation.
The Committee on Ways and Means received an additional referral
for the bill because it includes Medicare provisions that fall
within the jurisdiction of the Committee, including changes to
relevant provisions of the Social Security Act. As the
Committee explores the impact health care payer and provider
consolidation has on patients and taxpayers, it is the
Committee's priority to protect and strengthen competition in
the health care market. This resulted in the Committee
considering the role the Centers for Medicare and Medicaid
Services (CMS) and the Center for Medicare and Medicaid
Innovation (CMMI) may have impacting health care consolidation.
C. Legislative History
Committee Action
The Committee on Ways and Means marked up H.R. 3284, the
``Providers and Payers COMPETE Act,'' on July 26, 2023, and
ordered the bill, as amended, favorably reported (with a quorum
being present).
D. Legislative History
Pursuant to clause 3(c)(6) of rule XIII, the following
hearings were used to develop and consider H.R. 3284:
Committee on Ways and Means Health Sub-Committee Hearing,
``Why Health Care is Unaffordable: Anticompetitive and
Consolidated Markets.''
II. EXPLANATION OF THE BILL
A. Ensuring HHS Considers the Potential Impacts of Medicare Regulations
and Payments Have on Consolidation and Competition
PRESENT LAW
Section 553 of U.S. Code sets standards for the
Administration's rule making procedures.
Section 1315a(b)(4)(A) of the Social Security Act instructs
the Secretary to evaluate CMMI models based on two factors, the
quality of care furnished under the model and the changes in
spending generated by the model.
REASONS FOR CHANGE
The Committee observes that consolidation in the health
care marketplace has frequently resulted in increased costs and
worse outcomes for patients. The Committee observes that
despite being the single largest health care payer and
responsible for regulating nearly all health care facilities
and providers, CMS does not seek comment on how their payment
models and regulatory changes may impact competition and
consolidation in the health care marketplace. This policy
ensures the effects such models may have on payer and provider
consolidation is considered by CMS and CMMI. The Committee also
notes that providing this information in an annual report
submitted to Congress will further inform Congress on the
impacts Medicare rules have on health care consolidation and
may serve as a resource for potential legislative
considerations.
EXPLANATION OF PROVISION
This provision requires HHS to annually submit a report to
Congress on the potential aggregate impact of payment rules and
regulations for Medicare Parts A, B, C, and D from the previous
year. Additionally, CMS is required to seek public comment on
potential impacts of proposed rules on provider and payer
consolidation as part of the notice and comment rulemaking
process. Additionally, CMMI is also required to consider how
payment models impact provider and payer consolidation as part
of their model evaluation.
EFFECTIVE DATE
The provision applies to CMS rulemaking and CMMI models
beginning on January 1, 2025.
III. VOTE OF THE COMMITTEE
Pursuant to clause 3(b) of rule XIII of the Rules of the
House of Representatives, the following statement is made
concerning the vote of the Committee on Ways and Means in its
consideration of H.R. 3284, the ``Providers and Payers COMPETE
Act'' on July 26, 2023.
H.R. 3284 was ordered favorably reported to the House of
Representatives as amended by a roll call vote of 23 yeas to 17
nays (with a quorum being present). The vote was as follows:
----------------------------------------------------------------------------------------------------------------
Representative Yea Nay Present Representative Yea Nay Present
----------------------------------------------------------------------------------------------------------------
Mr. Smith (MO)..................... X ...... ......... Mr. Neal............. ...... X .........
Mr. Buchanan....................... X ...... ......... Mr. Doggett.......... ...... X .........
Mr. Smith (NE)..................... X ...... ......... Mr. Thompson......... ...... X .........
Mr. Kelly.......................... X ...... ......... Mr. Larson........... ...... X .........
Mr. Schweikert..................... X ...... ......... Mr. Blumenauer....... ...... X .........
Mr. LaHood......................... X ...... ......... Mr. Pascrell......... ...... X .........
Dr. Wenstrup....................... X ...... ......... Mr. Davis............ ...... X .........
Mr. Arrington...................... ...... ...... ......... Ms. Sanchez.......... ...... X .........
Dr. Ferguson....................... X ...... ......... Mr. Higgins.......... ...... X .........
Mr. Estes.......................... X ...... ......... Ms. Sewell........... ...... ...... .........
Mr. Smucker........................ X ...... ......... Ms. DelBene.......... ...... X .........
Mr. Hern........................... X ...... ......... Ms. Chu.............. ...... X .........
Ms. Miller......................... X ...... ......... Ms. Moore............ ...... X .........
Dr. Murphy......................... X ...... ......... Mr. Kildee........... ...... X .........
Mr. Kustoff........................ X ...... ......... Mr. Beyer............ ...... X .........
Mr. Fitzpatrick.................... X ...... ......... Mr. Evans............ ...... X .........
Mr. Steube......................... X ...... ......... Mr. Schneider........ ...... X .........
Ms. Tenney......................... X ...... ......... Mr. Panetta.......... ...... X .........
Mrs. Fischbach..................... ...... ...... .........
Mr. Moore.......................... X ...... .........
Mrs. Steel......................... X ...... .........
Ms. Van Duyne...................... X ...... .........
Mr. Feenstra....................... X ...... .........
Ms. Malliotakis.................... X ...... .........
Mr. Carey.......................... X ...... .........
----------------------------------------------------------------------------------------------------------------
IV. BUDGET EFFECTS OF THE BILL
A. Committee Estimate of Budgetary Effects
In compliance with clause 3(d) of rule XIII of the Rules of
the House of Representatives, a cost estimate provided by the
Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974 was not made available to the
Committee in time for the filing of this report. The Chairman
of the Committee shall cause such estimate to be printed in the
Congressional Record upon its receipt by the Committee.
B. Statement Regarding New Budget Authority and Tax Expenditures Budget
Authority
In compliance with clause 3(c)(2) of rule XIII of the Rules
of the House of Representatives, the Committee states that the
bill involves no new or increased budget authority.
V. OTHER MATTERS TO BE DISCUSSED UNDER THE RULES OF THE HOUSE
A. Committee Oversight Findings and Recommendations
With respect to clause 3(c)(1) of rule XIII of the Rules of
the House of Representatives, the Committee made findings and
recommendations that are reflected in this report.
B. Statement of General Performance Goals and Objectives
With respect to clause 3(c)(4) of rule XIII of the Rules of
the House of Representatives, the Committee advises that the
bill does not authorize funding, so no statement of general
performance goals and objectives is required.
C. Information Relating to Unfunded Mandates
This information is provided in accordance with section 423
of the Unfunded Mandates Reform Act of 1995 (Pub. L. No. 104-
4).
The Committee has determined that the bill does not contain
Federal mandates on the private sector. The Committee has
determined that the bill does not impose a Federal
intergovernmental mandate on State, local, or tribal
governments.
D. Congressional Earmarks, Limited Tax Benefits, and Limited Tariff
Benefits
With respect to clause 9 of rule XXI of the Rules of the
House of Representatives, the Committee has carefully reviewed
the provisions of the bill, and states that the provisions of
the bill do not contain any congressional earmarks, limited tax
benefits, or limited tariff benefits within the meaning of the
rule.
E. Duplication of Federal Programs
In compliance with clause 3(c)(5) of rule XIII of the Rules
of the House of Representatives, the Committee states that no
provision of the bill establishes or reauthorizes: (1) a
program of the Federal Government known to be duplicative of
another Federal program; (2) a program included in any report
from the Government Accountability Office to Congress pursuant
to section 21 of Public Law 111-139; or (3) a program related
to a program identified in the most recent Catalog of Federal
Domestic Assistance, published pursuant to the Federal Program
Information Act (Pub. L. No. 95-220, as amended by Pub. L. No.
98-169).
VI. CHANGES IN EXISTING LAW MADE BY THE BILL, AS REPORTED
Changes in Existing Law Proposed by the Bill, as Reported
Changes in Existing Law Made by the Bill, as Reported
In compliance with clause 3(e) of rule XIII of the Rules of
the House of Representatives, changes in existing law made by
the bill, as reported, are shown as follows (existing law
proposed to be omitted is enclosed in black brackets, new
matter is printed in italics, and existing law in which no
change is proposed is shown in roman):
SOCIAL SECURITY ACT
* * * * * * *
TITLE XI--GENERAL PROVISIONS, PEER REVIEW, AND ADMINISTRATIVE
SIMPLIFICATION
* * * * * * *
Part A--General Provisions
* * * * * * *
center for medicare and medicaid innovation
Sec. 1115A. (a) Center for Medicare and Medicaid Innovation
Established.--
(1) In general.--There is created within the Centers
for Medicare & Medicaid Services a Center for Medicare
and Medicaid Innovation (in this section referred to as
the ``CMI'') to carry out the duties described in this
section. The purpose of the CMI is to test innovative
payment and service delivery models to reduce program
expenditures under the applicable titles while
preserving or enhancing the quality of care furnished
to individuals under such titles. In selecting such
models, the Secretary shall give preference to models
that also improve the coordination, quality, and
efficiency of health care services furnished to
applicable individuals defined in paragraph (4)(A).
(2) Deadline.--The Secretary shall ensure that the
CMI is carrying out the duties described in this
section by not later than January 1, 2011.
(3) Consultation.--In carrying out the duties under
this section, the CMI shall consult representatives of
relevant Federal agencies, and clinical and analytical
experts with expertise in medicine and health care
management. The CMI shall use open door forums or other
mechanisms to seek input from interested parties.
(4) Definitions.--In this section:
(A) Applicable individual.--The term
``applicable individual'' means--
(i) an individual who is entitled to,
or enrolled for, benefits under part A
of title XVIII or enrolled for benefits
under part B of such title;
(ii) an individual who is eligible
for medical assistance under title XIX,
under a State plan or waiver; or
(iii) an individual who meets the
criteria of both clauses (i) and (ii).
(B) Applicable title.--The term ``applicable
title'' means title XVIII, title XIX, or both.
(5) Testing within certain geographic areas.--For
purposes of testing payment and service delivery models
under this section, the Secretary may elect to limit
testing of a model to certain geographic areas.
(b) Testing of Models (Phase I).--
(1) In general.--The CMI shall test payment and
service delivery models in accordance with selection
criteria under paragraph (2) to determine the effect of
applying such models under the applicable title (as
defined in subsection (a)(4)(B)) on program
expenditures under such titles and the quality of care
received by individuals receiving benefits under such
title.
(2) Selection of models to be tested.--
(A) In general.--The Secretary shall select
models to be tested from models where the
Secretary determines that there is evidence
that the model addresses a defined population
for which there are deficits in care leading to
poor clinical outcomes or potentially avoidable
expenditures. The Secretary shall focus on
models expected to reduce program costs under
the applicable title while preserving or
enhancing the quality of care received by
individuals receiving benefits under such
title. The models selected under this
subparagraph may include, but are not limited
to, the models described in subparagraph (B).
(B) Opportunities.--The models described in
this subparagraph are the following models:
(i) Promoting broad payment and
practice reform in primary care,
including patient-centered medical home
models for high-need applicable
individuals, medical homes that address
women's unique health care needs, and
models that transition primary care
practices away from fee-for-service
based reimbursement and toward
comprehensive payment or salary-based
payment.
(ii) Contracting directly with groups
of providers of services and suppliers
to promote innovative care delivery
models, such as through risk-based
comprehensive payment or salary-based
payment.
(iii) Utilizing geriatric assessments
and comprehensive care plans to
coordinate the care (including through
interdisciplinary teams) of applicable
individuals with multiple chronic
conditions and at least one of the
following:
(I) An inability to perform 2
or more activities of daily
living.
(II) Cognitive impairment,
including dementia.
(iv) Promote care coordination
between providers of services and
suppliers that transition health care
providers away from fee-for-service
based reimbursement and toward salary-
based payment.
(v) Supporting care coordination for
chronically-ill applicable individuals
at high risk of hospitalization through
a health information technology-enabled
provider network that includes care
coordinators, a chronic disease
registry, and home tele-health
technology.
(vi) Varying payment to physicians
who order advanced diagnostic imaging
services (as defined in section
1834(e)(1)(B)) according to the
physician's adherence to
appropriateness criteria for the
ordering of such services, as
determined in consultation with
physician specialty groups and other
relevant stakeholders.
(vii) Utilizing medication therapy
management services, such as those
described in section 935 of the Public
Health Service Act.
(viii) Establishing community-based
health teams to support small-practice
medical homes by assisting the primary
care practitioner in chronic care
management, including patient self-
management, activities.
(ix) Assisting applicable individuals
in making informed health care choices
by paying providers of services and
suppliers for using patient decision-
support tools, including tools that
meet the standards developed and
identified under section 936(c)(2)(A)
of the Public Health Service Act, that
improve applicable individual and
caregiver understanding of medical
treatment options.
(x) Allowing States to test and
evaluate fully integrating care for
dual eligible individuals in the State,
including the management and oversight
of all funds under the applicable
titles with respect to such
individuals.
(xi) Allowing States to test and
evaluate systems of all-payer payment
reform for the medical care of
residents of the State, including dual
eligible individuals.
(xii) Aligning nationally recognized,
evidence-based guidelines of cancer
care with payment incentives under
title XVIII in the areas of treatment
planning and follow-up care planning
for applicable individuals described in
clause (i) or (iii) of subsection
(a)(4)(A) with cancer, including the
identification of gaps in applicable
quality measures.
(xiii) Improving post-acute care
through continuing care hospitals that
offer inpatient rehabilitation, long-
term care hospitals, and home heal